Literature DB >> 12714509

CD2 engagement induces dendritic cell activation: implications for immune surveillance and T-cell activation.

Keith Crawford1, Aleksandra Stark, Betsy Kitchens, Kerry Sternheim, Vassilios Pantazopoulos, Ellen Triantafellow, Zhigang Wang, Baldev Vasir, Charles E Larsen, Dana Gabuzda, Ellis Reinherz, Chester A Alper.   

Abstract

We have shown previously that primary dendritic cells and monocytes express equal levels of CD14 but are distinguishable by the presence of CD2 on dendritic cells. CD2 is known to mediate the activation of T and natural killer (NK) cells through its interaction with CD58. CD2 epitopes recognized by anti-T111, -T112, and -T113 monoclonal antibodies (mAbs) are present on dendritic cells. Here we show that CD2 engagement significantly increases class II, costimulatory (CD40, CD80, CD86), adhesion (CD54, CD58), and CCR7 molecule expression on primary dendritic cells. Conversely, minimal or no change in the expression of the above antigens occurs on monocyte-derived dendritic cells, because these molecules are already maximally expressed. However, both kinds of dendritic cells release interleukin-1beta (IL-1beta) and IL-12 after CD2 engagement. Lastly, interference with dendritic cell CD2-T-cell CD58 engagement decreases naive CD4+CD45RA+ T-cell proliferation. Collectively, our results suggest another role of the CD2-CD58 pathway that allows nonimmune and immune cells to interact directly with dendritic cells and initiate innate and adaptive immune responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12714509     DOI: 10.1182/blood-2002-07-2206

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Enriched Cd141+ DCs in the joint are transcriptionally distinct, activated, and contribute to joint pathogenesis.

Authors:  Mary Canavan; Alice M Walsh; Vipul Bhargava; Sarah M Wade; Trudy McGarry; Viviana Marzaioli; Barry Moran; Monika Biniecka; Hannah Convery; Siobhan Wade; Carl Orr; Ronan Mullan; Jean M Fletcher; Sunil Nagpal; Douglas J Veale; Ursula Fearon
Journal:  JCI Insight       Date:  2018-12-06

2.  Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression.

Authors:  D J Lo; T A Weaver; L Stempora; A K Mehta; M L Ford; C P Larsen; A D Kirk
Journal:  Am J Transplant       Date:  2010-11-10       Impact factor: 8.086

3.  Activation antigens on colonic T cells in inflammatory bowel disease: effects of IL-10.

Authors:  E C Ebert; V Mehta; K M Das
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

4.  The novel immunotherapeutic molecule T11TS modulates glioma-induced changes of key components of the immunological synapse in favor of T cell activation and glioma abrogation.

Authors:  Suhnrita Chaudhuri; Manoj Kumar Singh; Debanjan Bhattacharya; Sagar Acharya; Sirshendu Chatterjee; Pankaj Kumar; Pushpak Bhattacharjee; Anjan Kumar Basu; Gaurisankar Sa; Tanya Das; Tushar Kanti Ghosh; Swapna Chaudhuri
Journal:  J Neurooncol       Date:  2014-07-16       Impact factor: 4.130

Review 5.  Searching for "signal 2": costimulation requirements of γδ T cells.

Authors:  Julie C Ribot; Ana debarros; Bruno Silva-Santos
Journal:  Cell Mol Life Sci       Date:  2011-05-04       Impact factor: 9.261

6.  Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients.

Authors:  A Daisy Narayan; Jessica L Chase; Rachel L Lewis; Xinghui Tian; Dan S Kaufman; James A Thomson; Esmail D Zanjani
Journal:  Blood       Date:  2005-11-08       Impact factor: 22.113

7.  Homotypic cell to cell cross-talk among human natural killer cells reveals differential and overlapping roles of 2B4 and CD2.

Authors:  Eun-Ok Kim; Tae-Jin Kim; Nayoung Kim; Sung Tae Kim; Vinay Kumar; Kyung-Mi Lee
Journal:  J Biol Chem       Date:  2010-09-02       Impact factor: 5.157

8.  Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas.

Authors:  Ellen H de Moll; Yichun Fu; Yingzhi Qian; Sara H Perkins; Shira Wieder; Sacha Gnjatic; Romain Remark; Sebastian G Bernardo; Marina Moskalenko; Jonathan Yao; Tammie Ferringer; Rui Chang; Jerry Chipuk; Basil A Horst; Miriam B Birge; Robert G Phelps; Yvonne M Saenger
Journal:  Cancer Immunol Immunother       Date:  2015-06-16       Impact factor: 6.968

9.  Blood fluke exploitation of non-cognate CD4+ T cell help to facilitate parasite development.

Authors:  Erika W Lamb; Colleen D Walls; John T Pesce; Diana K Riner; Sean K Maynard; Emily T Crow; Thomas A Wynn; Brian C Schaefer; Stephen J Davies
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

10.  Comprehensive gene expression profiling reveals synergistic functional networks in cerebral vessels after hypertension or hypercholesterolemia.

Authors:  Wei-Yi Ong; Mary Pei-Ern Ng; Sau-Yeen Loke; Shalai Jin; Ya-Jun Wu; Kazuhiro Tanaka; Peter Tsun-Hon Wong
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.